Hilde Laeremans

Title: Hilde Laeremans: Innovator in Molecular Medicine

Introduction

Hilde Laeremans is a prominent inventor based in Maastricht, Netherlands. She has made significant contributions to the field of molecular medicine, particularly through her innovative research and patenting activities. Her work focuses on developing antagonistic compounds that can aid in the healing process after myocardial infarction.

Latest Patents

Hilde Laeremans holds a patent for "Antagonistic peptides for frizzled-1 and frizzled-2." This invention provides antagonistic compounds for frizzled 1 and/or frizzled-2 receptors, which may be useful in molecular imaging of the wound healing process after myocardial infarction. The invention also offers therapeutic interventions into wound healing after remodeling of the heart, thereby ameliorating the consequences of myocardial infarction. The method involves antagonizing frizzled-1 or frizzled-2 receptors by contacting the receptor with a composition that includes a linear fragment of Wnt3(a) or Wnt5a or a functional analogue, which comprises at least one cysteine residue, one threonine residue, one aspartic acid residue, and one glycine residue. Hilde Laeremans has 1 patent to her name.

Career Highlights

Throughout her career, Hilde has worked with esteemed institutions such as Universiteit Maastricht and Academisch Ziekenhuis Maastricht. Her research has been pivotal in advancing the understanding of molecular mechanisms involved in wound healing and cardiac health.

Collaborations

Hilde has collaborated with notable colleagues, including Wessel Matthijs Blankesteijn and Tilman Mathias Hackeng. These partnerships have enriched her research and contributed to the development of innovative solutions in her field.

Conclusion

Hilde Laeremans is a trailblazer in molecular medicine, with her patent addressing critical health issues related to myocardial infarction. Her work exemplifies the impact of innovative research on improving medical outcomes.